Back to top
more

Illumina (ILMN)

(Delayed Data from NSDQ)

$161.93 USD

161.93
3,100,660

+2.84 (1.79%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $161.85 -0.08 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Can Illumina (ILMN) Spring a Surprise this Earnings Season?

by Zacks Equity Research

Illumina (ILMN) is well poised to witness steady top-line growth in Q2. Yet, the bottom line may remain stressed.

    Zacks Equity Research

    Illumina Offers FDA-Approved NGS Cancer Companion Test Kit

    by Zacks Equity Research

    Illumina, Inc. (ILMN) recently announced that its FDA-approved next-generation sequencing (NGS) -- Extended RAS Panel has met the Current Colorectal Cancer Guidelines.

      Mark Vickery headshot

      Top Research Reports for Today: CAT, T, LMT and DD

      by Mark Vickery

      Today's Research Daily features new research reports on 17 major stocks, including Caterpillar (CAT), AT&T (T), Lockheed Martin (LMT) and DuPont (DD).

        Zacks Equity Research

        Illumina (ILMN) Posts In-line Earnings in Q1, Margins Down

        by Zacks Equity Research

        Illumina Inc. (ILMN) reported adjusted earnings per share (EPS) of 64 cents in the first quarter of 2017

          Zacks Equity Research

          Should You Sell llumina (ILMN) Before Earnings?

          by Zacks Equity Research

          llumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

            Zacks Equity Research

            Can Illumina (ILMN) Spring a Surprise this Earnings Season?

            by Zacks Equity Research

            Illumina Inc. (ILMN), a leading provider of tools and integrated systems for analysis of genetic variation and function, is scheduled to report first-quarter 2017 financial results on Apr 25, after the closing bell.

              Mark Vickery headshot

              Top Research Reports for Today: MSFT, BLK, NOC

              by Mark Vickery

              Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), BlackRock (BLK), and Northrop Grumman (NOC).

                Zacks Equity Research

                Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe

                by Zacks Equity Research

                Illumina, Inc. (ILMN) recently announced the launch of a solution pertaining to its noninvasive prenatal testing (NIPT) range in Europe.

                  Sweta Killa headshot

                  Biotech ETFs Powered by Q4 Earnings

                  by Sweta Killa

                  Improved earnings are driving the biotech space and ETFs higher over the past 10 days.

                    Zacks Equity Research

                    Illumina (ILMN) Beats Q4 Earnings & Revenues, Guides 2017

                    by Zacks Equity Research

                    Illumina Inc. (ILMN) reported adjusted earnings per share (EPS) of 85 cents in the fourth quarter of 2016, which exceeded the Zacks Consensus Estimate by 4.9%.